It was a great pleasure sharing our thoughts on how to create more impact with DLIs …. It starts with registering what we do .. ashpublications.org/hematology/a... #ASH26 @ash.hematology.org
ashpublications.org
Posttransplant cells for the win? DLI and adoptive cell therapy to eradicate MRD
Abstract. Relapse remains the leading cause of failure after allogeneic stem cell transplantation (allo-SCT) for hematologic malignancies. Donor lymphocyte